0001209191-20-025811.txt : 20200427
0001209191-20-025811.hdr.sgml : 20200427
20200427164448
ACCESSION NUMBER: 0001209191-20-025811
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190628
FILED AS OF DATE: 20200427
DATE AS OF CHANGE: 20200427
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Keen Nicholas
CENTRAL INDEX KEY: 0001776881
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38916
FILM NUMBER: 20820698
MAIL ADDRESS:
STREET 1: C/O BICYCLE THEAPEUTICS LIMITED
STREET 2: B900 BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BICYCLE THERAPEUTICS plc
CENTRAL INDEX KEY: 0001761612
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: B900 BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
BUSINESS PHONE: 011441223261503
MAIL ADDRESS:
STREET 1: B900 BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
FORMER COMPANY:
FORMER CONFORMED NAME: BICYCLE THERAPEUTICS Ltd
DATE OF NAME CHANGE: 20181212
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2019-06-28
2019-05-30
0
0001761612
BICYCLE THERAPEUTICS plc
BCYC
0001776881
Keen Nicholas
C/O BICYCLE THERAPEUTICS PLC
B900, BABRAHAM RESEARCH CAMPUS
CAMBRIDGE
X0
CB22 3AT
UNITED KINGDOM
0
1
0
0
Chief Scientific Officer
Stock Option (Right to Buy)
14.00
2019-06-28
4
A
0
177404
0.00
A
2029-06-28
Ordinary Shares
177404
177404
D
The original Form 4 inadvertently listed the incorrect date of earliest transaction, transaction date and expiration date. This Form 4 amendment is being filed to accurately reflect the appropriates dates.
This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant.
/s/ Lee Kalowski, Attorney-in-Fact
2020-04-27